Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

March 10, 2022

An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio, together with SignalRx Pharmaceuticals Inc., have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division chief of hematology and medical oncology at UT […]




Mays Cancer Center researcher and SignalRx earn NCI business grants to develop drugs for first-in-human clinical trials

March 10, 2022

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – An internationally recognized physician-scientist of Mays Cancer Center at UT Health San Antonio together with SignalRx Pharmaceuticals Inc. have secured two National Cancer Institute business grants to further develop drugs on a pathway to first-in-human cancer clinical trials. The clinical translational researcher, Daruka Mahadevan, MD, PhD, division […]







First lady Jill Biden visits Mays Cancer Center, lauds its cancer research and its role in addressing Latino cancer health disparities

February 24, 2022

Contact: Steven Lee, 210-450-3823, lees22@uthscsa.edu SAN ANTONIO – First lady Jill Biden toured Mays Cancer Center at The University of Texas Health Science Center at San Antonio (UT Health San Antonio), and praised its efforts in addressing disparities in cancer rates among Latinos. The visit came on the same day as the opening of the […]

First lady Jill Biden speaks at Mays Cancer Center.